Ezogabine

DRUG3 trials

Sponsors

Icahn School of Medicine at Mount Sinai, Brian Wainger, James Murrough

Conditions

Amyotrophic Lateral SclerosisAnhedoniaDepressionDepressive DisorderMajor Depressive Disorder

Phase 2

Study to Treat Major Depressive Disorder (MDD) With a New Medication

CompletedNCT02149836

Icahn School of Medicine at Mount SinaiDepression, Major Depressive Disorder

Start: 2014-08-31End: 2016-12-31Updated: 2019-04-16

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

CompletedNCT02450552

Brian WaingerAmyotrophic Lateral Sclerosis

Start: 2015-06-30End: 2018-02-28Updated: 2019-08-28

Study to Treat Major Depressive Disorder With a New Medication

CompletedNCT03043560

James MurroughAnhedonia, Depressive Disorder

Start: 2017-09-25End: 2019-08-30Updated: 2020-10-23

Related Papers

Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis

JAMA Neurology2020-11-23128 citations